<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — Oktober 2012]]></title><description><![CDATA[<p dir="auto">meget sparsom volume op mod de 80. Det ligner en test allerede idag</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/451451/genmab-oktober-2012</link><generator>RSS for Node</generator><lastBuildDate>Fri, 19 Jun 2026 04:59:27 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/451451.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 10 Oct 2012 05:16:16 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:31:54 GMT]]></title><description><![CDATA[<p dir="auto">Vi håber nok begge de snart kan offentliggøre et salg til den bogførte værdi på 320 mio.:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068614</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068614</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:31:54 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:28:53 GMT]]></title><description><![CDATA[<p dir="auto">November 2, 2011; Copenhagen, Denmark;<br />
Interim Report for the 9 Months Ended September 30, 2011<br />
• Guidance for continuing operations improved due to reduction in expenses<br />
• Fair value of our manufacturing facility reduced by DKK 342 million and expected sale moved into 2012; guidance updated with new projected cash position</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068610</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068610</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:28:53 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:28:24 GMT]]></title><description><![CDATA[<p dir="auto">Men den fabrik er væk i 2012. Koste hvad det vil regnskabsteknisk. I cash får vi jo noget ud af det ligegyldig hvad</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068611</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068611</guid><dc:creator><![CDATA[investor1989]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:28:24 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:28:23 GMT]]></title><description><![CDATA[<p dir="auto">Det vil heller ikke være første gange de nedskriver frabrikken under salgsprocessen. F.eks Q3-2011</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068608</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068608</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:28:23 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:28:03 GMT]]></title><description><![CDATA[<p dir="auto">Selvfølgelig er det ikke så simpelt. Men det er altså bare ikke sjovt for en køber at give 300 for noget hvis selv kun værdisætter det til 200 <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f604.png?v=de222e39001" class="not-responsive emoji emoji-android emoji--smile" style="height:23px;width:auto;vertical-align:middle" title=":D" alt="😄" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068613</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068613</guid><dc:creator><![CDATA[investor1989]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:28:03 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:18:37 GMT]]></title><description><![CDATA[<p dir="auto">Hvis sammenhænget er så simpelt, synes jeg de skal opskrive væedien af fabrikken:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068609</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068609</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:18:37 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:10:36 GMT]]></title><description><![CDATA[<p dir="auto">Jeg tror 200 i nettosalg er hvad vi vil se. Men for min skyld vil jeg være tilfreds med 0 kr. Bare vi kan få den væk, fjernet pletten på blomsten og fjerne fremtidige costs</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068605</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068605</guid><dc:creator><![CDATA[investor1989]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:10:36 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:09:56 GMT]]></title><description><![CDATA[<p dir="auto">Det vil være tåbeligt. En eventuel køber kigger jo på genmab regnskab og ser hvad de selv mener den er værd. Hvis genmab siger 200 i deres regnskab giver ingen køber nok give 300 <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f604.png?v=de222e39001" class="not-responsive emoji emoji-android emoji--smile" style="height:23px;width:auto;vertical-align:middle" title=":D" alt="😄" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068606</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068606</guid><dc:creator><![CDATA[investor1989]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:09:56 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 18:09:28 GMT]]></title><description><![CDATA[<p dir="auto">De laver ikke en nedjusteringen af værdien af fabrikken før den er solgt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068604</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068604</guid><dc:creator><![CDATA[investor1989]]></dc:creator><pubDate>Wed, 31 Oct 2012 18:09:28 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 17:51:32 GMT]]></title><description><![CDATA[<p dir="auto">Spændende om de opjusterer på ny eller benytter lejligheden til at skære endnu en luns af den trælse fabrik.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068601</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068601</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Wed, 31 Oct 2012 17:51:32 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 17:14:09 GMT]]></title><description><![CDATA[<p dir="auto">jeg elsker salgstallen. Det er terra firma.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068607</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068607</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Wed, 31 Oct 2012 17:14:09 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 16:33:24 GMT]]></title><description><![CDATA[<p dir="auto">Genmabben er monster spændende. Men salgstallene skal lige sive ind hos analytikere. Det er jo ikke sådan noget tryk på knappen ligeså snart de får mailen. De store skal altid lige afveje alting før de går igang</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068612</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068612</guid><dc:creator><![CDATA[investor1989]]></dc:creator><pubDate>Wed, 31 Oct 2012 16:33:24 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:10:18 GMT]]></title><description><![CDATA[<p dir="auto">jeg har ikke noget problem med at øge min position rimeligt kraftigt igen, hvis tallene fortsætter</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068600</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068600</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:10:18 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:05:01 GMT]]></title><description><![CDATA[<p dir="auto">i like it</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068602</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068602</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:05:01 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:04:59 GMT]]></title><description><![CDATA[<p dir="auto">Dreaming :<br />
-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068603</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068603</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:04:59 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:04:43 GMT]]></title><description><![CDATA[<p dir="auto">Blot 10% til ofa og det giver 200 kurspoint ...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068597</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068597</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:04:43 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:02:19 GMT]]></title><description><![CDATA[<p dir="auto">Monster marked over 10 MIA USD</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068598</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068598</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:02:19 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:01:20 GMT]]></title><description><![CDATA[<p dir="auto">TEVA sælger alene for 4 mia USD i MS</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068593</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068593</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:01:20 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 14:00:59 GMT]]></title><description><![CDATA[<p dir="auto">Worldwide sales of Teva's treatment for multiple sclerosis, Copaxone, rose 12% to $982 million for the second quarter from $877 million for the corresponding quarter, accounting for half of Teva's brand drug sales and a fifth of its total sales</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068596</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068596</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Wed, 31 Oct 2012 14:00:59 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 13:59:43 GMT]]></title><description><![CDATA[<p dir="auto">så længe de stadig rekrutere patietner så kommer der tidligst resultater om 10 mdr.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068599</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068599</guid><dc:creator><![CDATA[troldmanden]]></dc:creator><pubDate>Wed, 31 Oct 2012 13:59:43 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 13:57:39 GMT]]></title><description><![CDATA[<p dir="auto">Spændende om det giver lige så gode resultater som iv. - Iøvrigt et stort fase2 studie 196 patienter kørt igennem på et år!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068591</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068591</guid><dc:creator><![CDATA[MadsSkjern]]></dc:creator><pubDate>Wed, 31 Oct 2012 13:57:39 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 13:52:45 GMT]]></title><description><![CDATA[<p dir="auto">Primary completion date: december 2012</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068592</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068592</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Wed, 31 Oct 2012 13:52:45 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 13:52:29 GMT]]></title><description><![CDATA[<p dir="auto"><a href="http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Multiple-Sclerosis-Drugs.htm" rel="nofollow ugc">http://pharma.about.com/od/Sales_and_Marketing/tp/Top-Multiple-Sclerosis-Drugs.htm</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068587</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068587</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Wed, 31 Oct 2012 13:52:29 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Oktober 2012 on Wed, 31 Oct 2012 13:52:09 GMT]]></title><description><![CDATA[<p dir="auto">så blev jeg klogere igen</p>
]]></description><link>https://dev.proinvestor.com/forum/post/10068594</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/10068594</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Wed, 31 Oct 2012 13:52:09 GMT</pubDate></item></channel></rss>